173 related articles for article (PubMed ID: 25173109)
1. An UPLC-MS/MS method for separation and accurate quantification of tamoxifen and its metabolites isomers.
Arellano C; Allal B; Goubaa A; Roché H; Chatelut E
J Pharm Biomed Anal; 2014 Nov; 100():254-261. PubMed ID: 25173109
[TBL] [Abstract][Full Text] [Related]
2. Quantification of tamoxifen and three of its phase-I metabolites in human plasma by liquid chromatography/triple-quadrupole mass spectrometry.
Binkhorst L; Mathijssen RH; Ghobadi Moghaddam-Helmantel IM; de Bruijn P; van Gelder T; Wiemer EA; Loos WJ
J Pharm Biomed Anal; 2011 Dec; 56(5):1016-23. PubMed ID: 21872414
[TBL] [Abstract][Full Text] [Related]
3. An ultra performance liquid chromatography-tandem MS assay for tamoxifen metabolites profiling in plasma: first evidence of 4'-hydroxylated metabolites in breast cancer patients.
Dahmane E; Mercier T; Zanolari B; Cruchon S; Guignard N; Buclin T; Leyvraz S; Zaman K; Csajka C; Decosterd LA
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Dec; 878(32):3402-14. PubMed ID: 21094101
[TBL] [Abstract][Full Text] [Related]
4. Development of a high-performance liquid chromatography method with fluorescence detection for the routine quantification of tamoxifen, endoxifen and 4-hydroxytamoxifen in plasma from breast cancer patients.
Rangel-Méndez JA; Graniel-Sabido MJ; Sánchez-Cruz JF; Moo-Puc R
Biomed Chromatogr; 2019 Apr; 33(4):e4462. PubMed ID: 30536934
[TBL] [Abstract][Full Text] [Related]
5. Active tamoxifen metabolite plasma concentrations after coadministration of tamoxifen and the selective serotonin reuptake inhibitor paroxetine.
Stearns V; Johnson MD; Rae JM; Morocho A; Novielli A; Bhargava P; Hayes DF; Desta Z; Flockhart DA
J Natl Cancer Inst; 2003 Dec; 95(23):1758-64. PubMed ID: 14652237
[TBL] [Abstract][Full Text] [Related]
6. Ultra-high performance liquid chromatography tandem mass spectrometric method for the determination of tamoxifen, N-desmethyltamoxifen, 4-hydroxytamoxifen and endoxifen in dried blood spots--development, validation and clinical application during breast cancer adjuvant therapy.
Antunes MV; Raymundo S; de Oliveira V; Staudt DE; Gössling G; Peteffi GP; Biazús JV; Cavalheiro JA; Tre-Hardy M; Capron A; Haufroid V; Wallemacq P; Schwartsmann G; Linden R
Talanta; 2015 Jan; 132():775-84. PubMed ID: 25476377
[TBL] [Abstract][Full Text] [Related]
7. Fast and Adequate Liquid Chromatography-Tandem Mass Spectrometric Determination of Z-endoxifen Serum Levels for Therapeutic Drug Monitoring.
de Krou S; Rosing H; Nuijen B; Schellens JH; Beijnen JH
Ther Drug Monit; 2017 Apr; 39(2):132-137. PubMed ID: 28045782
[TBL] [Abstract][Full Text] [Related]
8. Limited predictive value of achieving beneficial plasma (Z)-endoxifen threshold level by CYP2D6 genotyping in tamoxifen-treated Polish women with breast cancer.
Hennig EE; Piatkowska M; Karczmarski J; Goryca K; Brewczynska E; Jazwiec R; Kluska A; Omiotek R; Paziewska A; Dadlez M; Ostrowski J
BMC Cancer; 2015 Aug; 15():570. PubMed ID: 26232141
[TBL] [Abstract][Full Text] [Related]
9. Volumetric Absorptive Microsampling as a New Biosampling Tool for Monitoring of Tamoxifen, Endoxifen, 4-OH Tamoxifen and N-Desmethyltamoxifen in Breast Cancer Patients.
Maggadani BP; Harmita ; Haryono SJ; Rinaldi MR; Harahap Y
Drug Des Devel Ther; 2021; 15():2417-2430. PubMed ID: 34113081
[TBL] [Abstract][Full Text] [Related]
10. Importance of highly selective LC-MS/MS analysis for the accurate quantification of tamoxifen and its metabolites: focus on endoxifen and 4-hydroxytamoxifen.
Jager NG; Rosing H; Linn SC; Schellens JH; Beijnen JH
Breast Cancer Res Treat; 2012 Jun; 133(2):793-8. PubMed ID: 22388692
[TBL] [Abstract][Full Text] [Related]
11. Fast method for simultaneous quantification of tamoxifen and metabolites in dried blood spots using an entry level LC-MS/MS system.
Tré-Hardy M; Capron A; Antunes MV; Linden R; Wallemacq P
Clin Biochem; 2016 Nov; 49(16-17):1295-1298. PubMed ID: 27498307
[TBL] [Abstract][Full Text] [Related]
12. Reductive amination-assisted quantitation of tamoxifen and its metabolites by liquid phase chromatography tandem mass spectrometry.
Liang SS; Wang TN; Chiu CC; Kuo PL; Huang MF; Liu MC; Tsai EM
J Chromatogr A; 2016 Feb; 1434():64-9. PubMed ID: 26814364
[TBL] [Abstract][Full Text] [Related]
13. Tamoxifen metabolite isomer separation and quantification by liquid chromatography-tandem mass spectrometry.
Jaremko M; Kasai Y; Barginear MF; Raptis G; Desnick RJ; Yu C
Anal Chem; 2010 Dec; 82(24):10186-93. PubMed ID: 21086978
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of tamoxifen and metabolites by LC-MS/MS and HPLC methods.
Heath DD; Flat SW; Wu AH; Pruitt MA; Rock CL
Br J Biomed Sci; 2014; 71(1):33-9. PubMed ID: 24693573
[TBL] [Abstract][Full Text] [Related]
15. Development of a methodology to quantify tamoxifen and endoxifen in breast cancer patients by micellar liquid chromatography and validation according to the ICH guidelines.
Aranda EO; Esteve-Romero J; Rambla-Alegre M; Peris-Vicente J; Bose D
Talanta; 2011 Apr; 84(2):314-8. PubMed ID: 21376950
[TBL] [Abstract][Full Text] [Related]
16. Development and validation of a liquid chromatography-mass spectrometry assay for quantification of Z- and E- isomers of endoxifen and its metabolites in plasma from women with estrogen receptor positive breast cancer.
Buhrow SA; Koubek EJ; Goetz MP; Ames MM; Reid JM
J Chromatogr B Analyt Technol Biomed Life Sci; 2023 Apr; 1221():123654. PubMed ID: 37004493
[TBL] [Abstract][Full Text] [Related]
17. Sensitive HPLC-PDA determination of tamoxifen and its metabolites N-desmethyltamoxifen, 4-hydroxytamoxifen and endoxifen in human plasma.
Antunes MV; Rosa DD; Viana Tdos S; Andreolla H; Fontanive TO; Linden R
J Pharm Biomed Anal; 2013 Mar; 76():13-20. PubMed ID: 23291438
[TBL] [Abstract][Full Text] [Related]
18. Development and validation of an UPLC-MS/MS method for the quantification of tamoxifen and its main metabolites in human scalp hair.
Drooger JC; Jager A; Lam MH; den Boer MD; Sleijfer S; Mathijssen RH; de Bruijn P
J Pharm Biomed Anal; 2015 Oct; 114():416-25. PubMed ID: 26119504
[TBL] [Abstract][Full Text] [Related]
19. Determination of tamoxifen and endoxifen in dried blood spots using LC-MS/MS and the effect of coated DBS cards on recovery and matrix effects.
Jager NG; Rosing H; Schellens JH; Beijnen JH
Bioanalysis; 2014; 6(22):2999-3009. PubMed ID: 25496254
[TBL] [Abstract][Full Text] [Related]
20. Determination of tamoxifen and its main metabolites in plasma samples from breast cancer patients by micellar liquid chromatography.
Peris-Vicente J; Ochoa-Aranda E; Bose D; Esteve-Romero J
Talanta; 2015 Jan; 131():535-40. PubMed ID: 25281137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
